Flexmort

Flexible Mortuary Solutions

Tel: +44 (0) 8455 333561 | Email: info@flexmort.com

July 01, 2015

The increasing availability of DNA based technologies, and the rapidly falling price and increasing precision of sequencing, is leading to a revolution in medical care. This is generally referred at as Personalised Medicine and in reality means using DNA-based data to try and predict responses to therapy to allow more precise tailoring of therapy options. In the future, DNA data will be key to understanding disease in general and individual variations both in disease outcomes and response to treatment. Having access to one’s DNA heritage would greatly aid the understanding of many diseases such as prostate cancer, where it is clear that inherited risk is complex and multifactorial. For families with rare diseases, again access to stored familial DNA may well help care in the future, even if the precise nature of the inherited problem is not currently fully understood.

About the Author

Leave a Reply

*

captcha *

free instagram followers instagram takipçi hilesi